NYU Langone establishes unique neuromodulation center

NewsGuard 100/100 Score

The Department of Neurosurgery at NYU Langone Medical Center has established a unique, multidisciplinary neuromodulation center for the treatment of complex neurological conditions including movement disorders like Parkinson's disease, chronic pain and psychiatric condition such as obsessive compulsive disorder and severe depression.

"Neuromodulation includes deep brain stimulation (DBS), spinal cord and peripheral nerve stimulation as well as targeted drug delivery - procedures that are minimally invasive and are safe alternative for those suffering from these conditions," said Alon Y. Mogilner, MD, PhD, faculty member, Department of Neurosurgery and director of NYU Langone's Neuromodulation Center.

DBS uses mild electrical stimulation to restore or improve function or reduce pain by correcting abnormal electrical or chemical activity in the brain. A small pulse-generator is inserted just below the skin by a specially-trained neurosurgeon, which transmits pulses through microelectrodes applied to targeted areas in the brain or along nerves known to be associated with the condition. The program generating the pulses can be easily reversed, modified or turned off for periods of time to offer more flexible treatment and measurable results.

The Center specializes in two types of neuromodulation techniques, deep brain stimulation (DBS), an FDA-approved treatment successful for helping patients with complex movement disorders and peripheral neurostimulation (PNS), a growing specialty for potentially treating chronic headaches or severe facial pain - which can cause disabling psychological, sociological or financial distress and an inability to work or maintain healthy relationships.

The Neuromodulation Center is also conducting research investigating the effectiveness of DBS in treating disorders such as depression and Tourette's syndrome, as well as clinical trials utilizing the latest advantages in technology to better treat Parkinson's disease. Scientists and clinicians anticipate neuromodulation will also result in effective treatment for headache pain, psychiatric disorders and neurological conditions such as Alzheimer's disease.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Esketamine after childbirth cuts risk of postnatal depression by three-quarters